Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 6/20 | 0.85 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.85 |
| ▸ | ABCG2 | Q9UNQ0 | 4/20 | 0.85 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.85 |
| ▸ | HPGD | P15428 | 4/20 | 0.85 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.85 |
| ▸ | TP53 | P04637 | 3/20 | 0.85 |
| ▸ | MAPT | P10636 | 3/20 | 0.85 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.85 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.85 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.85 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.85 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.85 |
| ▸ | NFKB1 | P19838 | 4/20 | 0.81 |
| ▸ | NFKB2 | Q00653 | 3/20 | 0.81 |
| ▸ | RELA | Q04206 | 3/20 | 0.81 |
| ▸ | CTSL | P07711 | 2/20 | 0.79 |
| ▸ | MAOB | P27338 | 2/20 | 0.72 |
| ▸ | TUBB1 | Q9H4B7 | 1/20 | 0.72 |
| ▸ | LMNA | P02545 | 3/20 | 0.71 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL633170 | 1.00 | MEN1 (0.85) | MEN1KMT2AABCG2CYP3A4HPGD | |
| SCHEMBL25206351 | 1.00 | MEN1 (0.85) | MEN1KMT2AABCG2CYP3A4HPGD | |
| SCHEMBL30383806 | 0.92 | ABCG2 (1.00) | MEN1KMT2AABCG2CYP3A4HPGD | |
| SCHEMBL25217986 | 0.92 | ABCG2 (1.00) | MEN1KMT2AABCG2CYP3A4HPGD | |
| SCHEMBL633470 | 0.92 | ABCG2 (1.00) | MEN1KMT2AABCG2CYP3A4HPGD | |
| SCHEMBL633469 | 0.92 | ABCG2 (1.00) | MEN1KMT2AABCG2CYP3A4HPGD | |
| SCHEMBL25234197 | 0.91 | ABCG2 (0.85) | MEN1KMT2AABCG2CYP3A4HPGD | |
| Ethane SCHEMBL25195312 | 0.91 | ABCG2 (0.97) | MEN1KMT2AABCG2CYP3A4HPGD | |
| SCHEMBL21527688 | 0.91 | ABCG2 (0.85) | MEN1KMT2AABCG2CYP3A4HPGD | |
| SCHEMBL21527689 | 0.91 | ABCG2 (0.85) | MEN1KMT2AABCG2CYP3A4HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 51 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4655410-A2 | O-METHYLATION OF PHENOLIC SUBSTANCES VIA FUNGAL O-METHYLTRANSFERASE | Symrise AG (DE) | 2025-12-03 | — | — | EP | claimed |
| WO-2024156359-A1 | O-METHYLATION OF PHENOLIC SUBSTANCES VIA FUNGAL O-METHYLTRANSFERASE | SYMRISE AG (DE) | 2024-08-02 | — | — | WO | claimed |
| WO-2024156879-A2 | O-METHYLATION OF PHENOLIC SUBSTANCES VIA FUNGAL O-METHYLTRANSFERASE | SYMRISE AG (DE) | 2024-08-02 | — | — | WO | claimed |
| US-20240150797-A1 | BIOCATALYTICAL PRODUCTION OF DIHYDROCHALCONES | SYMRISE AG (DE) | 2024-05-09 | — | — | US | claimed |
| EP-4301865-A1 | BIOCATALYTICAL PRODUCTION OF DIHYDROCHALCONES | Symrise AG (DE) | 2024-01-10 | — | — | EP | claimed |
| US-20230099567-A1 | COMPOSITION FOR TREATMENT, PREVENTION, OR AMELIORATION OF LYMPHEDEMA | RAPPELER CO., LTD. (KR) | 2023-03-30 | — | — | US | claimed |
| WO-2022184248-A1 | BIOCATALYTICAL PRODUCTION OF DIHYDROCHALCONES | SYMRISE AG (DE) | 2022-09-09 | — | — | WO | claimed |
| US-9877946-B2 | Method for treating, managing, inhibiting, or preventing obesity | Research & Business Foundation Sungkyunkwan University (KR) | 2018-01-30 | — | — | US | claimed |
| US-20170087126-A1 | COMPOSITION FOR INDUCING DIFFERENTIATION INTO BEIGE AND BROWN ADIPOCYTES AND METHOD OF INDUCING THE SAME | RESEARCH & BUSINESS FOUNDATION SUNGKYUNKWAN UNIVER SITY (KR) | 2017-03-30 | — | — | US | claimed |
| US-9549908-B2 | Composition for inducing differentiation into beige and brown adipocytes and method of inducing the same | Research & Business Foundation Sungkyunkwan University, Ltd. (KR) | 2017-01-24 | — | — | US | claimed |
| US-20150374643-A1 | COMPOSITION FOR INDUCING DIFFERENTIATION INTO BEIGE AND BROWN ADIPOCYTES AND METHOD OF INDUCING THE SAME | Research & Business Foundation Sungkyunkwan University (KR) | 2015-12-31 | — | — | US | claimed |
| EP-1888174-B1 | USE OF CHALCONES FOR THE TREATMENT OF VIRAL DISORDERS | JOHNSON & JOHNSON CONSUMER (US) | 2012-02-22 | — | — | EP | claimed |
| EP-1888174-A1 | USE OF CHALCONES FOR THE TREATMENT OF VIRAL DISORDERS | Johnson and Johnson Consumer Companies, Inc. (US) | 2008-02-20 | — | — | EP | claimed |
| WO-2006127539-A1 | USE OF CHALCONES FOR THE TREATMENT OF VIRAL DISORDERS | JOHNSON & JOHNSON CONSUMER COMPANIES, INC. (US) | 2006-11-30 | — | — | WO | claimed |
| US-20060270614-A1 | Use of chalcones for the treatment of viral disorders | JOHNSON & JOHNSON CONSUMER COMPANIES, INC. | 2006-11-30 | — | — | US | claimed |
| EP-4747367-A1 | NEW ENZYMES FOR THE MANUFACTURING OF 4'-O-METHYLATED PHENOLIC SUBSTANCES | Symrise AG (DE) | 2026-05-27 | — | — | EP | disclosed |
| EP-3713561-B1 | COMBINATION OF BUTEIN, ISOLIQUIRITIGENIN AND SULFURETIN, AND ITS USE FOR THE TREATMENT OF DIABETES AND ASSOCIATED DISORDERS | OTAGO INNOVATION LTD (NZ) | 2026-05-06 | — | — | EP | disclosed |
| EP-0370461-B1 | Chalcone derivatives and process for producing the same | DAINIPPON INK & CHEMICALS (JP) | 1995-06-28 | — | — | EP | disclosed |
| US-5068364-A | Antiulcer agents, antiallergens | DAINIPPON INK AND CHEMICALS, INC. (JP) | 1991-11-26 | — | — | US | disclosed |
| EP-0370461-A2 | Chalcone derivatives and process for producing the same | DAINIPPON INK AND CHEMICALS, INC. (JP) | 1990-05-30 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170087126-A1 | COMPOSITION FOR INDUCING DIFFERENTIATION INTO BEIGE AND BROWN ADIPOCYTES AND METHOD OF INDUCING THE SAME | FABP4, PLIN1, PRDM7 | MEN1 3611/4885KMT2A 2456/4885ABCG2 3473/4885 |
| US-20150374643-A1 | COMPOSITION FOR INDUCING DIFFERENTIATION INTO BEIGE AND BROWN ADIPOCYTES AND METHOD OF INDUCING THE SAME | FABP4, PLIN1, PRDM7 | MEN1 3611/4885KMT2A 2456/4885ABCG2 3473/4885 |
| US-20060270614-A1 | Use of chalcones for the treatment of viral disorders | HAVCR2, HMGB3, EIF2AK2 | MEN1 3326/4885KMT2A 4014/4885ABCG2 3800/4885 |
| US-20230099567-A1 | COMPOSITION FOR TREATMENT, PREVENTION, OR AMELIORATION OF LYMPHEDEMA | LIPG, LPL, LTA | MEN1 4247/4885KMT2A 3466/4885ABCG2 1942/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.